The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia

Erstveröffentlichung
2009Authors
Giannopoulos, K.
Mertens, D.
Buehler, A.
Barth, Thomas F. E.
Idler, I.
Wissenschaftlicher Artikel
Published in
Leukemia ; 23 (2009), 3. - S. 519-527. - ISSN 0887-6924
Link to publication
https://dx.doi.org/10.1038/leu.2008.338Institutions
UKU. Klinik für Innere Medizin IIIUKU. Institut für Pathologie
Subject headings
[Free subject headings]: B-cell chronic lymphocytic leukemia (B-CLL) | tumor-associated antigens (TAAs) | cytotoxic T lymphocytes (CTL) | receptor for hyaluronic acid mediated motility (RHAMM/CD168) | tumor-associated antigens | acute myeloid-leukemia | multiple-myeloma | mutation status | soluble cd44 | high-risk | expression | rhamm | disease | protein[DDC subject group]: DDC 610 / Medicine & health